gms | German Medical Science

102. Jahrestagung der DOG

Deutsche Ophthalmologische Gesellschaft e. V.

23. bis 26.09.2004, Berlin

Heavy versus standard silicone Oil as Endotamponade in Pars Plana Vitrectomy (HSO-Study)

Meeting Abstract

Search Medline for

Evidenzbasierte Medizin - Anspruch und Wirklichkeit. 102. Jahrestagung der Deutschen Ophthalmologischen Gesellschaft. Berlin, 23.-26.09.2004. Düsseldorf, Köln: German Medical Science; 2004. Doc04dogSA.13.14

The electronic version of this article is the complete one and can be found online at: http://www.egms.de/en/meetings/dog2004/04dog395.shtml

Published: September 22, 2004

© 2004 Joussen.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

Aim: Improvement of the surgical therapy outcome for aphakic or pseudophakic patients with PVR grade C-A6 by selection of a more specific endotamponade

Study Design: Parallel group design, two treatments

Treatments: Surgery with standard silicone oil endotamponade versus surgery without heavy silicone oil endotamponade

Patients: Phakic, aphakic or pseudophakic patients with PVR grade C-A6

Time of the Study: 4 years

Endotamponades: Heavy silicone oil, standard silicone oil

Inclusion Criteria:

Inferior and posterior PVR grade C-A6, P12 according to Machemer at 10 over 6 to 2 hours (PVR only as rhegmatogenous retinal detachment or a complication of trauma)

Inferior giant retinal tear retinal detachment at 10 over 6 to 2 hours

Exclusion Criteria:

Diabetic retinopathy

Glaucoma

Retinotomy/holes/tears above 2 and 10 o'clock

Superior anterior PVR grade C A6 between 2, 12 and 10 o'clock

Superior giant retinal tear retinal detachment between 2, 12 and 10 o'clock

No written informed consent

Age below 18 years

Participation at another trial

Pregnancy

Primary Endpoint:

Twelve months attachment

Twelve months visual acuity

Secondary Endpoint:

Three months attachment

Number of Re-operations

Quality of life

Principal Investigator: Prof. Dr. Bernd Kirchhof, Cologne

Koordination: PD Dr. A. Joussen, Cologne

Medical Statistics: Prof. Dr. Ralf-Dieter Hilgers, Aachen

Sponsor:

DFG

Fluoron, Neu Ulm/Geuder Heidelberg

Current status: Ethics comittee approved, recruitment ongoing